The prognostic role of end-of-treatment FDG-PET/CT in diffuse large B cell lymphoma: a pilot study application of neural networks to predict time-to-event.

Journal: Annals of nuclear medicine
PMID: 33094420

Abstract

PURPOSE: To evaluate the prognostic role of end-of-treatment (EoT) FDG-PET/CT parameters in diffuse large B cell lymphoma (DLBCL), and then to explore a pilot application of Neural Networks (NN) in predicting time-to-relapse.

Authors

  • Salvatore Annunziata
    Institute of Nuclear Medicine, Università Cattolica del Sacro Cuore, Largo Agostino Gemelli 8, 00168, Roma, Italia. salvatoreannunziata@live.it.
  • Armando Pelliccioni
    INAIL-DiMEILA, Monte Porzio Catone, Roma, Italia.
  • Stefan Hohaus
    Institute of Hematology, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Elena Maiolo
    Institute of Hematology, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Annarosa Cuccaro
    Institute of Hematology, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Alessandro Giordano
    Institute of Nuclear Medicine, Università Cattolica del Sacro Cuore, Largo Agostino Gemelli 8, 00168, Roma, Italia.

Keywords

External Resources

Popular Topics
Recent Journals